Sunshine Biopharma (SBFM) Competitors $1.65 +0.20 (+13.79%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$1.63 -0.02 (-1.15%) As of 07:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. NRSN, TPST, CARA, TENX, LSTA, CYTH, FBLG, KLTO, NNVC, and BCABShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include NeuroSense Therapeutics (NRSN), Tempest Therapeutics (TPST), Cara Therapeutics (CARA), Tenax Therapeutics (TENX), Lisata Therapeutics (LSTA), Cyclo Therapeutics (CYTH), FibroBiologics (FBLG), Klotho Neurosciences (KLTO), NanoViricides (NNVC), and BioAtla (BCAB). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. Its Competitors NeuroSense Therapeutics Tempest Therapeutics Cara Therapeutics Tenax Therapeutics Lisata Therapeutics Cyclo Therapeutics FibroBiologics Klotho Neurosciences NanoViricides BioAtla NeuroSense Therapeutics (NASDAQ:NRSN) and Sunshine Biopharma (NASDAQ:SBFM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Which has preferable earnings and valuation, NRSN or SBFM? Sunshine Biopharma has higher revenue and earnings than NeuroSense Therapeutics. NeuroSense Therapeutics is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroSense TherapeuticsN/AN/A-$10.21M-$0.54-3.52Sunshine Biopharma$34.87M0.22-$5.13M-$150.88-0.01 Which has more risk and volatility, NRSN or SBFM? NeuroSense Therapeutics has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Comparatively, Sunshine Biopharma has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Is NRSN or SBFM more profitable? NeuroSense Therapeutics has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -13.88%. NeuroSense Therapeutics' return on equity of 0.00% beat Sunshine Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets NeuroSense TherapeuticsN/A N/A -445.40% Sunshine Biopharma -13.88%-21.25%-16.89% Do analysts rate NRSN or SBFM? NeuroSense Therapeutics presently has a consensus price target of $14.00, indicating a potential upside of 636.84%. Sunshine Biopharma has a consensus price target of $15.00, indicating a potential upside of 809.09%. Given Sunshine Biopharma's higher possible upside, analysts clearly believe Sunshine Biopharma is more favorable than NeuroSense Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroSense Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor NRSN or SBFM? In the previous week, NeuroSense Therapeutics had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for NeuroSense Therapeutics and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 0.96 beat NeuroSense Therapeutics' score of 0.93 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroSense Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sunshine Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in NRSN or SBFM? 1.0% of NeuroSense Therapeutics shares are held by institutional investors. Comparatively, 42.0% of Sunshine Biopharma shares are held by institutional investors. 27.4% of NeuroSense Therapeutics shares are held by insiders. Comparatively, 0.1% of Sunshine Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryNeuroSense Therapeutics and Sunshine Biopharma tied by winning 7 of the 14 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SBFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.61M$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E Ratio-0.0121.3126.2319.90Price / Sales0.22278.47413.23113.66Price / CashN/A41.4736.1356.90Price / Book0.187.518.045.38Net Income-$5.13M-$55.05M$3.15B$248.50M7 Day Performance12.24%2.07%1.44%2.04%1 Month Performance6.45%4.84%3.62%4.84%1 Year Performance419.36%5.37%34.68%20.23% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma3.2279 of 5 stars$1.65+13.8%$15.00+809.1%+415.0%$6.61M$34.87M-0.013News CoverageGap UpHigh Trading VolumeNRSNNeuroSense Therapeutics2.3234 of 5 stars$1.89-0.5%$14.00+640.7%+53.2%$25.97MN/A-3.5010News CoverageTPSTTempest Therapeutics1.833 of 5 stars$6.80-1.4%$30.00+341.2%-74.1%$25.41MN/A-0.3820CARACara Therapeutics0.3203 of 5 starsN/AN/AN/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeTENXTenax Therapeutics1.5827 of 5 stars$5.76-1.5%$17.50+203.8%+81.1%$24.27MN/A-2.329Positive NewsGap UpLSTALisata Therapeutics2.6061 of 5 stars$2.90+3.6%$15.00+417.2%-21.1%$24.12M$1M-1.2630CYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809FBLGFibroBiologics3.0728 of 5 stars$0.62+0.7%$13.00+1,989.4%-85.3%$23.65MN/A-2.9610Positive NewsKLTOKlotho NeurosciencesN/A$1.13+56.9%N/AN/A$23.40MN/A-3.14N/ANews CoverageHigh Trading VolumeNNVCNanoViricides0.933 of 5 stars$1.40flatN/A-21.9%$22.50MN/A-1.9420News CoveragePositive NewsGap DownBCABBioAtla2.6307 of 5 stars$0.40+3.1%$5.00+1,162.6%-69.9%$22.43M$11M-0.3260Positive NewsGap Up Related Companies and Tools Related Companies NRSN Competitors TPST Competitors CARA Competitors TENX Competitors LSTA Competitors CYTH Competitors FBLG Competitors KLTO Competitors NNVC Competitors BCAB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBFM Stock Alerts